PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 41 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $221,000 | -73.2% | 2,226,961 | 0.0% | 0.02% | -79.5% |
Q2 2016 | $824,000 | -1.4% | 2,226,961 | +1.2% | 0.12% | -7.1% |
Q1 2016 | $836,000 | -2.6% | 2,200,000 | 0.0% | 0.13% | +22.3% |
Q4 2015 | $858,000 | -32.2% | 2,200,000 | 0.0% | 0.10% | -49.0% |
Q3 2015 | $1,265,000 | +6.5% | 2,200,000 | 0.0% | 0.20% | +27.8% |
Q2 2015 | $1,188,000 | – | 2,200,000 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HOME FEDERAL BANK OF TENNESSEE | 100,000 | $6,000 | 0.00% |
LEE DANNER & BASS INC | 50,000 | $3,000 | 0.00% |
Ancora Advisors LLC | 14,650 | $1,000 | 0.00% |
Diversified Trust Co | 50,000 | $3,000 | 0.00% |
CAPTRUST FINANCIAL ADVISORS | 57,659 | $3,000 | 0.00% |
ACADEMY CAPITAL MANAGEMENT INC/TX | 20,000 | $1,000 | 0.00% |
HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |